BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6641123)

  • 1. Serum and urine analysis of the aminoterminal procollagen peptide type III by radioimmunoassay with antibody Fab fragments.
    Rohde H; Langer I; Krieg T; Timpl R
    Coll Relat Res; 1983 Sep; 3(5):371-9. PubMed ID: 6641123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassays for type III procollagen amino-terminal peptides in humans.
    Niemelä O
    Clin Chem; 1985 Aug; 31(8):1301-4. PubMed ID: 4017234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long-term follow-up study.
    Bentsen KD; Hørslev-Petersen K; Junker P; Juhl E; Lorenzen I
    Liver; 1987 Apr; 7(2):96-105. PubMed ID: 3613881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay for the amino-terminal sequences of type III procollagen in human body fluids measuring fragmented precursor sequences.
    Pierard D; Nusgens BV; Lapiere CM
    Anal Biochem; 1984 Aug; 141(1):127-36. PubMed ID: 6496923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis.
    Bentsen KD; Henriksen JH; Bendtsen F; Hørslev-Petersen K; Lorenzen I
    Hepatology; 1990 Jun; 11(6):957-63. PubMed ID: 2365293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis in alcoholics. Detection by Fab radioimmunoassay of serum procollagen III peptides.
    Sato S; Nouchi T; Worner TM; Lieber CS
    JAMA; 1986 Sep; 256(11):1471-3. PubMed ID: 3747065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma.
    Krieg T; Langer I; Gerstmeier H; Keller J; Mensing H; Goerz G; Timpl R
    J Invest Dermatol; 1986 Dec; 87(6):788-91. PubMed ID: 3782862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity.
    McCullough AJ; Stassen WN; Wiesner RH; Czaja AJ
    Hepatology; 1987; 7(1):49-54. PubMed ID: 3492417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial determinations of the amino-terminal peptide of type III procollagen in severe chronic active hepatitis.
    McCullough AJ; Stassen WN; Wiesner RH; Czaja AJ
    J Lab Clin Med; 1987 Jan; 109(1):55-61. PubMed ID: 3794515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
    Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
    Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
    Niemelä O; Risteli L; Sotaniemi EA; Risteli J
    Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum type III procollagen and basement membrane proteins as noninvasive markers of hepatic pathology in Indian childhood cirrhosis.
    Trivedi P; Risteli J; Risteli L; Tanner MS; Bhave S; Pandit AN; Mowat AP
    Hepatology; 1987; 7(6):1249-53. PubMed ID: 3679089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical properties of the aminopropeptide of procollagen type III.
    Rohde H; Bruckner P; Timpl R
    Eur J Biochem; 1983 Sep; 135(2):197-202. PubMed ID: 6192992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen.
    Risteli J; Niemi S; Trivedi P; Mäentausta O; Mowat AP; Risteli L
    Clin Chem; 1988 Apr; 34(4):715-8. PubMed ID: 3359606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary excretion of procollagen type III peptide in healthy humans and in patients with alcoholic cirrhosis of the liver.
    Raedsch R; Stiehl A; Sieg A; Walker S; Kommerell B
    Gastroenterology; 1983 Dec; 85(6):1265-70. PubMed ID: 6628925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum.
    Niemelä O; Risteli L; Sotaniemi EA; Risteli J
    Clin Chim Acta; 1982 Sep; 124(1):39-44. PubMed ID: 7127838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of aminoterminal type III procollagen peptide in normal subjects and hepatic fibrosis.
    Nakano H; Nakabayashi H; Okamoto Y; Kawasaki T; Seko S; Fukuda Y
    Gastroenterol Jpn; 1985 Dec; 20(6):573-6. PubMed ID: 4085749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease.
    Nouchi T; Worner TM; Sato S; Lieber CS
    Alcohol Clin Exp Res; 1987 Jun; 11(3):287-91. PubMed ID: 3307495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoterminal propeptide of type III procollagen: a marker of disease activity in schistosomal patients.
    Fayol V; Hassanein HI; el-Badrawy N; Ville G; Hartmann DJ
    Eur J Clin Chem Clin Biochem; 1991 Nov; 29(11):737-41. PubMed ID: 1782280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher levels of serum aminoterminal type III procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhosis of equal severity.
    Lotterer E; Gressner AM; Kropf J; Grobe E; von Knebel D; Bircher J
    J Hepatol; 1992 Jan; 14(1):71-7. PubMed ID: 1737919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.